ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
121.130,39
0,30%
S&P 500
6.037,42
1,06%
US Dollar vs BRL
6,7426
0,13%
Bitcoin
95.722,37
-3,60%
Brent Oil
73,075
-0,29%
As Melhores Corretoras Online
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Osmotica Pharmaceuticals PLC (OSMT)

  7. Osmotica Pharmaceuticals PLC (OSMT) Notícias

OSMT

Osmotica Pharmaceuticals (OSMT)

Osmotica Pharmaceuticals PLC
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:OSMT
DataHoraFonteTítuloCódigoCompanhia
16/06/202317:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
11/05/202317:24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
24/04/202317:26Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
24/04/202317:17Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
24/04/202317:13Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
08/03/202318:26Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
27/01/202318:11Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
26/01/202319:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
12/08/202217:07Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
11/08/202216:53Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
09/08/202218:21Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
12/04/202218:05Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
30/03/202217:52Edgar (US Regulatory)Annual Report (10-k)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
19/01/202213:38GlobeNewswire Inc.UPDATE – Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales GuidanceNASDAQ:OSMTOsmotica Pharmaceuticals PLC
19/01/202208:50GlobeNewswire Inc.Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales GuidanceNASDAQ:OSMTOsmotica Pharmaceuticals PLC
18/01/202208:50GlobeNewswire Inc.RVL Pharmaceuticals to Host UPNEEQ® Overview and Business Update Webcast on January 19, 2022NASDAQ:OSMTOsmotica Pharmaceuticals PLC
06/01/202210:55GlobeNewswire Inc.Osmotica Pharmaceuticals plc to Host UPNEEQ® Overview and Business Update Call on January 19, 2022NASDAQ:OSMTOsmotica Pharmaceuticals PLC
23/12/202108:15TipRanksH.C. Wainwright Thinks Osmotica Pharmaceuticals’ Stock is Going to RecoverNASDAQ:OSMTOsmotica Pharmaceuticals PLC
20/12/202118:05GlobeNewswire Inc.Osmotica Pharmaceuticals plc to Present at H.C. Wainwright Bioconnect ConferenceNASDAQ:OSMTOsmotica Pharmaceuticals PLC
16/11/202119:13Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
15/11/202118:05GlobeNewswire Inc.Osmotica Pharmaceuticals plc Reports Third Quarter 2021 Results and Provides Business UpdateNASDAQ:OSMTOsmotica Pharmaceuticals PLC
15/11/202108:50GlobeNewswire Inc.Osmotica Pharmaceuticals plc to Present at Jefferies London Virtual Healthcare Conference 2021NASDAQ:OSMTOsmotica Pharmaceuticals PLC
11/11/202121:30GlobeNewswire Inc.Osmotica Pharmaceuticals plc to Provide Third Quarter 2021 Business and Financial Update on November 15, 2021NASDAQ:OSMTOsmotica Pharmaceuticals PLC
22/10/202117:28Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
13/10/202117:45GlobeNewswire Inc.Osmotica Pharmaceuticals plc Announces Closing of $35 Million Underwritten Public OfferingNASDAQ:OSMTOsmotica Pharmaceuticals PLC
08/10/202118:14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
07/10/202110:04GlobeNewswire Inc.Osmotica Pharmaceuticals plc Announces Debt Financing from Athyrium Capital Management of up to $100 MillionNASDAQ:OSMTOsmotica Pharmaceuticals PLC
07/10/202101:31GlobeNewswire Inc.Osmotica Pharmaceuticals Announces Pricing of $35 Million Underwritten Public OfferingNASDAQ:OSMTOsmotica Pharmaceuticals PLC
06/10/202117:26GlobeNewswire Inc.Osmotica Pharmaceuticals plc Announces Proposed Underwritten Public OfferingNASDAQ:OSMTOsmotica Pharmaceuticals PLC
22/09/202118:00GlobeNewswire Inc.Osmotica Pharmaceuticals plc to Present at Cantor Virtual Global Healthcare Conference 2021NASDAQ:OSMTOsmotica Pharmaceuticals PLC
 Apresentando as notícias mais relevantes sobre:NASDAQ:OSMT

Seu Histórico Recente

EU
MLUMG
Umalis
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados